CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 8-K Event Material agreement
- 8-K Event Executive or director change
- 8-K Event Other events
- S-3ASR Offering Registration Statement
- 4 Open-market sale Chief Commercial Officer sold 1,407 shares at $17.12 ($24,086)
- 4 Open-market sale Chief Executive Officer sold 7,836 shares at $17.12 ($134,142)
- 4 Open-market sale Chief Medical Officer sold 1,407 shares at $17.12 ($24,085)
- 4 Open-market sale Senior Vice President, R&D sold 1,407 shares at $17.12 ($24,085)
- 4 Open-market sale SVP, GC & Corporate Secretary sold 1,407 shares at $17.12 ($24,086)
- 4 Open-market sale Chief Financial Officer sold 1,407 shares at $17.12 ($24,085)
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market sale Chief Medical Officer sold 1,250 shares at $13.81 ($17,263)
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change
- 4 Open-market sale Chief Executive Officer sold 9,562 shares at an average $14.62 ($139,797)
- 8-K Event Other events
- 8-K Event Executive or director change · Shareholder vote results
Page 29 of 65 · 1,286 filings